Multiple Myeloma
Multiple Myeloma
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
43
Clinical Trials
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-179041-BELANTAMAB-P-L
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient P-L
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-179401-BELANTAMAB-A-V
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient A-V
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-179751-BELANTAMAB-W-B
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient W-B
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-179753-BELANTAMAB-R-S
Single Patient Non-Emergency Use IND of Belantamab Mafodotin for Patient R-S
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / SIND-180535-BELANTAMAB-W-T
Single Patient IND of Belantamab mafodotin for Patient W-T
Learn More
Multiple Myeloma
N/A
Enrolling
nct/study# N/A / TALQUETAMAB-OUTCOMES
Real World Outcomes of patients with Relapsed/ Refractory Multiple Myeloma on Talquetamab
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.